Clinical Trial Update: Long-Term Follow Up Study for AMD3100 Patients

View source ↗

Summary

Long-term follow-up data from a completed trial evaluating AMD3100 (plerixafor) in patients with multiple myeloma were reported by MD Anderson Cancer Center. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• AMD3100 (plerixafor) (plerixafor)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloma | Status: COMPLETED